TipRanks
Advertisement
Advertisement
AbCellera to present Phase 2 Data for ABCL635 at IMS Congress on Menopause
PremiumThe FlyAbCellera to present Phase 2 Data for ABCL635 at IMS Congress on Menopause
22d ago
AbCellera Biologics call volume above normal and directionally bullish
Premium
The Fly
AbCellera Biologics call volume above normal and directionally bullish
23d ago
AbCellera rises 17.0%
Premium
The Fly
AbCellera rises 17.0%
1M ago
AbCellera Biologics call volume above normal and directionally bullish
PremiumThe FlyAbCellera Biologics call volume above normal and directionally bullish
2M ago
AbCellera Biologics Announces Oversubscribed $200 Million Offering
Premium
Company Announcements
AbCellera Biologics Announces Oversubscribed $200 Million Offering
2M ago
AbCellera announces $200M common stock, warrants offering
Premium
The Fly
AbCellera announces $200M common stock, warrants offering
2M ago
AbCellera Earnings Call Balances Cash Strength With Risk
PremiumCompany AnnouncementsAbCellera Earnings Call Balances Cash Strength With Risk
2M ago
AbCellera to Report Phase 2 Menopause Therapy Data
Premium
Company Announcements
AbCellera to Report Phase 2 Menopause Therapy Data
2M ago
AbCellera price target raised to $9 from $8 at Stifel
Premium
The Fly
AbCellera price target raised to $9 from $8 at Stifel
2M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―